Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab

Fitzgerald, T; Melsheimer, R; Lafeuille, MH; Lefebvre, P; Morrison, L; Woodruff, K; Lin, I; Emond, B

Emond, B (corresponding author), Anal Grp Inc, 1190 Ave Canadiens de Montreal, Montreal, PQ H3B 0G7, Canada.

BIOLOGICS-TARGETS & THERAPY, 2021; 15 ():

Abstract

Objective: To compare switching and discontinuation patterns of patients stable on originator infliximab (IFX) who switched to an IFX biosimilar (swit......

Full Text Link